| 2.01 0.02 (1.01%) | 04-13 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.42 | 1-year : | 2.83 |
| Resists | First : | 2.07 | Second : | 2.42 |
| Pivot price | 1.85  |
|||
| Supports | First : | 1.68 | Second : | 1.44 |
| MAs | MA(5) : | 1.96 |
MA(20) : | 1.81 |
| MA(100) : | 3.17  |
MA(250) : | 6.27 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 85.6 |
D(3) : | 84.4 |
| RSI | RSI(14): 55.6 |
|||
| 52-week | High : | 12.18 | Low : | 1.44 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ ZCMD ] has closed below upper band by 7.7%. Bollinger Bands are 69.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 31 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.03 - 2.04 | 2.04 - 2.05 |
| Low: | 1.9 - 1.91 | 1.91 - 1.92 |
| Close: | 1.99 - 2.01 | 2.01 - 2.02 |
Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand. The company operates through its mdmooc.org online platform under the MDMOOC brand; and Sunshine Health Forums, a Wechat subscription account and mobile app. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China.
Wed, 25 Mar 2026
Zhongchao (NASDAQ: ZCMD) director discloses 1,925 Class A share stake - Stock Titan
Thu, 19 Mar 2026
Zhongchao (ZCMD) director General John Conrad reports 1,925 Class A shares - Stock Titan
Thu, 19 Mar 2026
Zhongchao Regains Nasdaq Compliance on Minimum Bid Price - The Globe and Mail
Thu, 26 Feb 2026
Zhongchao announces 1-for-8 reverse stock split effective March 2 - Investing.com
Thu, 26 Feb 2026
Zhongchao cancer-care platform shrinks share count 8-to-1 to stay on Nasdaq - Stock Titan
Thu, 26 Feb 2026
Zhongchao Inc. Announces 1-for-8 Share Consolidation - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 3 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 26.1 (%) |
| Held by Institutions | 0.3 (%) |
| Shares Short | 32 (K) |
| Shares Short P.Month | 19 (K) |
| EPS | -1.52 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.38 |
| Profit Margin | -13 % |
| Operating Margin | -15.7 % |
| Return on Assets (ttm) | -3 % |
| Return on Equity (ttm) | -6 % |
| Qtrly Rev. Growth | -33 % |
| Gross Profit (p.s.) | 2.13 |
| Sales Per Share | 4.07 |
| EBITDA (p.s.) | -0.28 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -1 (M) |
| PE Ratio | -1.33 |
| PEG Ratio | 0 |
| Price to Book value | 0.31 |
| Price to Sales | 0.49 |
| Price to Cash Flow | -14.02 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|